Structure Therapeutics (GPCR) Retained Earnings (2022 - 2026)

Structure Therapeutics' Retained Earnings history runs 5 years deep, the most recent figure standing at -$546.3 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 67130.67% year-over-year to -$546.3 million; the TTM figure through Mar 2026 stood at -$546.3 million (down 67130.67% YoY), while the FY2025 annual figure was $1.1 million, up 15.32% from the prior year.
• Retained Earnings was -$546.3 million for Q1 2026 at Structure Therapeutics, down from $1.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $2.8 million in Q3 2024 to a low of -$546.3 million in Q1 2026.
• Historically, Retained Earnings has averaged -$138.5 million across 5 years, with a median of -$288500.0 in 2024.
• Biggest YoY gain for Retained Earnings was 1005.56% in 2025; the steepest drop was 89756.26% in 2025.
• A 5-year view of Retained Earnings shows it stood at -$117.0 million in 2022, then surged by 100.45% to $521000.0 in 2023, then surged by 75.43% to $914000.0 in 2024, then gained by 15.32% to $1.1 million in 2025, then sank by 51931.12% to -$546.3 million in 2026.
• The last three Retained Earnings figures came in at -$546.3 million (Q1 2026), $1.1 million (Q4 2025), and -$503.3 million (Q3 2025), per Business Quant data.